Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
about
Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinomaIntegrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.
P2860
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@ast
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@en
type
label
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@ast
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@en
prefLabel
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@ast
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
@en
P2093
Chih-Chi Kuo
Chin-Yu Liu
Chung-Bao Hsieh
Her-Young Su
Ming-De Yan
Mu-Hsien Yu
Wei-Ting Huang
Ya-Wen Lin
Yu-Lueng Shih
P2860
P304
P356
10.3748/WJG.V21.I13.3960
P407
P577
2015-04-01T00:00:00Z